Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V87650 | (R,R)-PCSK9 degrader 1 | 2216703-12-5 | (R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1. |
![]() |
V98991 | 7030B-C5 | 370871-42-4 | 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM). |
![]() |
V87653 | AZD8233 | 2604215-74-7 | AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis. |
![]() |
V87655 | AZD8233 sodium | AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. | |
![]() |
V98901 | BRD8518 | 1565828-01-4 | BRD8518 is a PCSK9 inhibitor (EC50=0.23 μM). |
![]() |
V87646 | Cepadacursen sodium | 2252375-14-5 | Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis. |
![]() |
V87648 | CVI-LM001 | CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect. | |
![]() |
V87324 | DC371739 | 2135765-21-6 | DC371739 is a potent, orally active PCSK9 inhibitor. |
![]() |
V87654 | E28362 | 930017-01-9 | E28362 is a small molecule PCSK9 inhibitor. |
![]() |
V99540 | MeIm | 2043947-71-1 | MeIm (compound 7) is a high-affinity PCSK9-targeting peptide mimetic with cholesterol-lowering activity. |
![]() |
V99859 | PCSK9 allosteric binder-1 | 2215932-06-0 | PCSK9 Allosteric Binder-1 (Example 70) is a PCSK9 allosteric binder. |
![]() |
V87649 | PCSK9-IN-26 | 3033361-09-7 | PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM). |
![]() |
V87651 | PCSK9-IN-27 | PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM). | |
![]() |
V87652 | PCSK9-IN-28 | PCSK9-IN-28 (Compound C11) is a PCSK9 inhibitor isolated from Euphorbia esula. | |
![]() |
V98057 | PCSK9-IN-29 | 1233353-86-0 | PCSK9-IN-29 is a lipid-lowering drug. |
![]() |
V97401 | PCSK9-IN-30 | PCSK9-IN-30 (compound 3f) is a PCSK9 inhibitor. | |
![]() |
V99662 | PCSK9-IN-31 | 2247649-76-7 | PCSK9-IN-31 (compound WX002) is an orally available PCSK9 inhibitor. |
![]() |
V94899 | PCSK9-IN-32 | PCSK9-IN-32 (Compound 8) is a PCSK9-GFP translation inhibitor. | |
![]() |
V6648 | PF-00932239 (R-IMPP) | 2133832-83-2 | PF-00932239 (R-IMPP) is a novel and potent inhibitor of PCSK9 translation. |
![]() |
V27359 | PF-06446846 hydrochloride | 1632250-50-0 | PF‑06446846 HCL (PF-6446846;PF6446846) is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor with anti-hyperlipidemic effects. |